Indiana Attorney General Todd Rokita is accusing Eli Lilly of conspiring with its competitors to artifically raise the price ...

The Oregon Department of Justice on Wednesday sued three of the nation’s largest insulin makers, accusing them of working ...

Oregon’s attorney general is suing six of the nation’s largest pharmaceutical companies and pharmacy benefit managers for ...

Oregon is joining cities, unions, and states across the country that have filed lawsuits alleging pharmacy benefit mangers ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

The lawsuit alleges three manufacturers coordinated with three pharmacy benefit managers in a scheme to inflate insulin ...

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin.

California will cap insulin co-pays at $35 and launch CalRx state-branded insulin in 2026 under new legislation signed by ...

Jefferson files a lawsuit alleging a nationwide scheme has driven the price of insulin up by as much as 1,000% in the last ...

Indiana Attorney General Todd Rokita on Monday announced a new lawsuit against Indianapolis-based drug maker Eli Lilly and Co ...